US20170081705A1 - Microfluidic Analysis System - Google Patents

Microfluidic Analysis System Download PDF

Info

Publication number
US20170081705A1
US20170081705A1 US15/278,894 US201615278894A US2017081705A1 US 20170081705 A1 US20170081705 A1 US 20170081705A1 US 201615278894 A US201615278894 A US 201615278894A US 2017081705 A1 US2017081705 A1 US 2017081705A1
Authority
US
United States
Prior art keywords
sample
carrier fluid
nucleic acid
acid molecules
thermal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US15/278,894
Other versions
US10676786B2 (en
Inventor
Mark Davies
Tara Dalton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stokes Bio Ltd
Original Assignee
Stokes Bio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34278702&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20170081705(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stokes Bio Ltd filed Critical Stokes Bio Ltd
Priority to US15/278,894 priority Critical patent/US10676786B2/en
Publication of US20170081705A1 publication Critical patent/US20170081705A1/en
Assigned to STOKES BIO LTD. reassignment STOKES BIO LTD. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DALTON, TARA, DAVIES, MARK
Priority to US16/892,488 priority patent/US11807902B2/en
Application granted granted Critical
Publication of US10676786B2 publication Critical patent/US10676786B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F25/00Flow mixers; Mixers for falling materials, e.g. solid particles
    • B01F25/10Mixing by creating a vortex flow, e.g. by tangential introduction of flow components
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01FMIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F33/00Other mixers; Mixing plants; Combinations of mixers
    • B01F33/30Micromixers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/50273Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by the means or forces applied to move the fluids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502769Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
    • B01L3/502776Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for focusing or laminating flows
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502769Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
    • B01L3/502784Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L7/00Heating or cooling apparatus; Heat insulating devices
    • B01L7/52Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples
    • B01L7/525Heating or cooling apparatus; Heat insulating devices with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples with physical movement of samples between temperature zones
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/08Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor using a stream of discrete samples flowing along a tube system, e.g. flow injection analysis
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0636Focussing flows, e.g. to laminate flows
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/06Fluid handling related problems
    • B01L2200/0673Handling of plugs of fluid surrounded by immiscible fluid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2200/00Solutions for specific problems relating to chemical or physical laboratory apparatus
    • B01L2200/14Process control and prevention of errors
    • B01L2200/141Preventing contamination, tampering
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0809Geometry, shape and general structure rectangular shaped
    • B01L2300/0816Cards, e.g. flat sample carriers usually with flow in two horizontal directions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/08Geometry, shape and general structure
    • B01L2300/0861Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/087Multiple sequential chambers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00Additional constructional details
    • B01L2300/18Means for temperature control
    • B01L2300/1838Means for temperature control using fluid heat transfer medium
    • B01L2300/185Means for temperature control using fluid heat transfer medium using a liquid as fluid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0403Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0409Moving fluids with specific forces or mechanical means specific forces centrifugal forces
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01LCHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00Moving or stopping fluids
    • B01L2400/04Moving fluids with specific forces or mechanical means
    • B01L2400/0475Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
    • B01L2400/0487Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N2035/00465Separating and mixing arrangements
    • G01N2035/00514Stationary mixing elements
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N35/00Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
    • G01N35/10Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices
    • G01N35/1095Devices for transferring samples or any liquids to, in, or from, the analysis apparatus, e.g. suction devices, injection devices for supplying the samples to flow-through analysers

Definitions

  • the invention relates to analysis systems for analysis such as Polymerase Chain Reaction (PCR) analysis to detect the population of rare mutated cells in a sample of bodily fluid and/or tissue.
  • PCR Polymerase Chain Reaction
  • a common method is to probe the sample using known genetic markers, the markers being specific to the type of mutation being sought, and then amplify the targets in the sample. If the mutations or chromosomal aberations are present then the amplification can be detected, usually using optical techniques.
  • PCR Polymerase Chain Reaction
  • 6,306,590 describes a method of performing a PCR in a microfluidic device, in which a channel heats, and then cools PCR reactants cyclically.
  • U.S. Pat. No. 6,670,153 also describes use of a microfluidic device for PCR.
  • the invention is directed towards providing an improved microfluidic analysis system for applications such as the above.
  • a biological sample analysis system comprising:
  • the analysis stages comprise a thermal cycling stage and an optical detection stage for performance of a polymerise chain reaction.
  • the sample preparation stage comprises a centrifuge for separation of samples from an input fluid and for introduction of the samples to the primary carrier fluid.
  • the centrifuge comprises a pair of opposed primary carrier fluid channels on either side of a vortex chamber, whereby flow of primary carrier fluid in said channels causes centrifuging of sample in the vortex chamber and flow of sample from the chamber into said channels.
  • contact between the sample and the vortex chamber surface is avoided by wrapping the sample in an initial carrier fluid within the chamber.
  • the controller directs separation in the centrifuge either radially or axially due to gravity according to nature of the input fluid such as blood containing the sample.
  • the primary carrier fluid velocity is in the range of 1 m/s to 20 m/s.
  • the thermal cycling stage comprises a microfluidic thermal device comprising a thermal zone comprising a sample inlet for flow of sample through a sample channel while enveloped in the primary carrier fluid, and a thermal carrier inlet for flow of a thermal carrier fluid to heat or cool the sample by heat conduction through the primary carrier fluid.
  • microfluidic thermal device thermal zone further comprises separate sample and thermal outlets positioned to allow flow of thermal carrier fluid into and out of contact with the primary carrier fluid.
  • the thermal cycling stage comprises a plurality of thermal zones.
  • the microfluidic thermal device comprises a plurality of thermal zones in series.
  • the thermal cycling stage comprises a plurality of microfluidic thermal devices in series.
  • the microfluidic thermal device comprises a closed sample channel for re-circulation of sample with successive heating or cooling in successive thermal zones.
  • the controller directs flow of the thermal and primary carrier fluids to control flowrate of sample by enveloping within the primary carrier fluid and by viscous drag between the thermal carrier fluid and the primary carrier fluid.
  • the primary carrier fluid is biologically non-reactive.
  • the primary carrier fluid is a silicone oil.
  • the thermal carrier fluid is biologically non-reactive.
  • the thermal carrier fluid is a silicone oil.
  • the temperatures and flowrates of the carrier fluids are controlled to achieve a temperature ramping gradient of 17° C./sec to 25° C./sec.
  • FIG. 1 is a diagram of an analysis system of the invention.
  • FIG. 2 is a diagrammatic plan view of a centrifuge of the system, and FIG. 3 is a simulation diagram showing centrifuging;
  • FIG. 4 is a perspective view of the main body of a microfluidic beater of the system
  • FIG. 5 is a prediction velocity and temperature plot along a thermal stage of the heater
  • FIG. 6 is a centre line temperature profile in the flow direction showing fast response of same in the heated zone.
  • FIG. 7 is a plan view of an alternative microfluidic heater.
  • an analysis system 1 comprises a controller 2 which interfaces with various stages.
  • a carrier fluid supply 4 delivers carrier fluid to a macro pump 5 which delivers it at a high flowrate to a sample preparation stage 6 .
  • the latter also receives a bio-fluid sample, and centrifuges the sample in a vortex created by carrier fluid flow, as described in more detail below.
  • Reactants are supplied by a supply 8 to a flow controller 7 which delivers streams of separated DNA with reactants enveloped in carrier fluid to a thermal cycling stage 9 .
  • the DNA is amplified in the stage 9 and optically detected by a detection stage 10 .
  • the samples are enveloped in a biologically non-reactive carrier fluid such as silicone oil. This avoids risk of contamination from residual molecules on system channel surfaces.
  • a centrifuge device 20 of the sample preparation stage 6 is illustrated diagrammatically. It comprises opposed carrier supply lines 21 and 22 and a central vortex chamber 23 having a sample inlet out of the plane of the page.
  • the centrifuge 20 operates by primary carrier fluid in the channels 21 and 22 driving sample fluid in the chamber 23 into a vortex via viscous forces at the interface between the two fluids.
  • the carrier fluid is silicone oil mixed to be neutrally buoyant with the sample.
  • FIG. 3 illustrates the centrifuging activity, the greater density of dots indicating higher flow velocities.
  • the left-hand scale shows the velocity range of 1 m/s to 20 m/s.
  • the sample is wrapped in an initial volume of carrier fluid within the chamber 23 to prevent surface contamination.
  • the carrier fluid is pumped at speeds of 5 ms ⁇ 1 through the system.
  • the desired carrier fluid speed is 1 m/s to 20 m/s.
  • the device has further potential to be miniaturized to centrifuge at up to 200,000 g, as these levels of force are necessary for efficient separation of RNA and other smaller cellular constituents and bio-molecules.
  • the continuous throughput centrifuge offers many benefits over conventional technology.
  • the device may also function as a fluid mixing device by reversing the flow path of one of the carrier fluid, if such is desired for an application. It is modular in nature, meaning two or more systems can be placed together in any configuration and run by the same control and power source system.
  • the centrifuge 20 has no moving parts thereby allowing excellent reliability compared with a system having moving pans. An important consequence of this feature is that manufacturing this device at the micro-scale using current silicon processing or micro-machining is readily achievable.
  • a microfluidic thermal device 51 of the stage 9 is shown. It comprises three successive thermal zones 52 , 53 , and 54 . Each zone comprises a sample inlet 60 and an outlet 61 for flow of the bio sample in the primary carrier fluid. There are also a pair of thermal carrier inlets 65 and 66 , and a pair of thermal carrier outlets 67 and 68 for each of the three zones.
  • This drawing shows only the main body, there also being top and bottom sealing transparent plates.
  • the bio sample which enters the sample inlet 60 of each stage is enveloped and conveyed by the carrier fluid henceforth called the “primary carrier fluid”.
  • Thermal carrier fluid is delivered at the inlets 65 and 66 to heat or cool the bio sample via the primary carrier fluid.
  • the arrangement of a number (in this case three) of thermal zones in series offers advantages to applications such as the polymerase chain reaction (PCR) where rapid and numerous thermal cycles lead to dramatic amplification of a DNA template strand.
  • PCR polymerase chain reaction
  • the device 51 also acts as an ejector pump, in which the velocity and hence the residency time of the sample is controlled by controlling velocity of one or both of the carriers fluids.
  • the carrier flow parameters determine how long the sample remains at the set temperature in each zone. This is often important, as chemical reactions require particular times for completion.
  • the device 51 can therefore be tuned to the required residency times and ramp rates by controlling the carrier velocity.
  • a predicted velocity contour map at the mid-height plane of a zone channel is shown.
  • Carrier fluid enters through the channels at the top and bottom left of the image and exits through the channels at the top and bottom right of the image.
  • the sample fluid enters and exits through the central channel.
  • the different shadings of this map indicate the velocities, the range being 0.01 m/s to 0.1 m/s.
  • sample fluid enters through the central channel at the left of the image at a temperature of 50° C. and is heated to 70° C. by the thermal carrier fluid.
  • FIG. 6 shows a temperature profile along a longitudinal centerline of a thermal zone.
  • a target temperature of 342 K is achieved within an extremely short distance from entrance, achieving an excellent temperature ramp rate of 20° C./sec over a distance of 0.05 m.
  • a ramping of 17° C./sec to 25° C./sec is desirable for many applications.
  • FIG. 7 another microfluidic thermal device, 70 , is shown.
  • the zones 71 and 73 are on one side and there is only a single zone, 72 , on the other side.
  • the thermal carrier fluid is silicone oil, as is the primary carrier fluid.
  • the thermal carrier fluid for the zone 71 is at 68° C., to ramp up the bio sample to this temperature during residency in this zone.
  • the zones 72 and 73 provide outlet temperatures of 95° C. and 72° C. respectively.
  • the optical detection stage 10 is positioned over the microfluidic device 70 to analyse the sample.
  • the silicone oil is sufficiently transparent to detect the fluorescently tagged molecules.
  • the invention achieves comprehensive control over bio sample flowrate and temperature, with no risk of contamination from device surfaces.
  • the invention also achieves integrated pumping and thermal cycling of the sample without moving parts at the microscale. There are very high throughputs as measured by processing time for one sample.
  • the system is expected to have a low cost and high reliability due to the absence of micro scale moving parts.
  • the system also allows independent control and variation of all PCR parameters for process optimisation.

Abstract

A microfluidic analysis system (1) performs polymerase chain reaction (PCR) analysis on a bio sample. In a centrifuge (6) the sample is separated into DNA and RNA constituents. The vortex is created by opposing flow of a silicon oil primary carrier fluid effecting circulation by viscous drag. The bio sample exits the centrifuge enveloped in the primary carrier fluid. This is pumped by a flow controller (7) to a thermal stage (9). The thermal stage (9) has a number of microfluidic devices (70) each having thermal zones (71, 72, 73) in which the bio sample is heated or cooled by heat conduction to/from a thermal carrier fluid and the primary carrier fluid. Thus, the carrier fluids envelope the sample, control its flowrate, and control its temperature without need for moving parts at the micro scale.

Description

  • This is a CONTINUATION of PCT/IE2004/000115 filed 6 Sep. 2004 and published in English, claiming the priorities of U.S. Application No. 60/500,344 and 60/500,345, both filed on 5 Sep. 2003.
  • FIELD OF THE INVENTION
  • The invention relates to analysis systems for analysis such as Polymerase Chain Reaction (PCR) analysis to detect the population of rare mutated cells in a sample of bodily fluid and/or tissue.
  • Prior Art Discussion
  • It is known for at least the past decade that cancers have a genetic cause. With the emergence of fast methods of sequencing and the publication of the human genome, the motivation and methods are available to find the genetic causes, both germline and somatic, of the most prevalent cancers. Contemporary oncological research suggests that there is a sequence of mutations that must occur for a cancer to be life-threatening, called the multistage model. Cancer could therefore be diagnosed earlier by detecting these genetic markers thereby increasing the probability of cure. However, even with refining of the sample, the target cells and their DNA are still usually very rare, perhaps one part in 106. The analysis system must therefore be able to perform very effective amplification.
  • There are several methods of attempting to identify rare cells in a sample of bio-fluid. A common method is to probe the sample using known genetic markers, the markers being specific to the type of mutation being sought, and then amplify the targets in the sample. If the mutations or chromosomal aberations are present then the amplification can be detected, usually using optical techniques.
  • It is also possible, depending on the amplification used, to use the Polymerase Chain Reaction (PCR) to detect the number of mutated cells in the original sample: a number important as firstly, it can be linked to the progress of the cancer and secondly, it provides a quantitative measure with which to diagnose remission. PCR is the enzyme-catalysed reaction used to amplify the sample. It entails taking a small quantity of DNA or RNA and producing many identical copies of it in vitro. A system to achieve a. PCR is to process the samples by thermally cycling them is described in U.S. Pat. No. 5,270,183. However, this apparently involves a risk of sample contamination by surfaces in the temperature zones and other channels. Also, U.S. Pat. No. 6,306,590 describes a method of performing a PCR in a microfluidic device, in which a channel heats, and then cools PCR reactants cyclically. U.S. Pat. No. 6,670,153 also describes use of a microfluidic device for PCR.
  • The invention is directed towards providing an improved microfluidic analysis system for applications such as the above.
  • SUMMARY OF THE INVENTION
  • According to the invention, there is provided a biological sample analysis system comprising:
      • a carrier fluid;
      • a sample supply;
      • a sample preparation stage for providing a flow of sample enveloped in a primary carrier fluid;
      • at least one analysis stage for performing analysis of the sample while controlling flow of the sample while enveloped within the primary carrier fluid without the sample contacting a solid surface; and a controller for controlling the system.
  • In one embodiment, the analysis stages comprise a thermal cycling stage and an optical detection stage for performance of a polymerise chain reaction.
  • In another embodiment, the sample preparation stage comprises a centrifuge for separation of samples from an input fluid and for introduction of the samples to the primary carrier fluid.
  • In a further embodiment, the centrifuge comprises a pair of opposed primary carrier fluid channels on either side of a vortex chamber, whereby flow of primary carrier fluid in said channels causes centrifuging of sample in the vortex chamber and flow of sample from the chamber into said channels.
  • In one embodiment, contact between the sample and the vortex chamber surface is avoided by wrapping the sample in an initial carrier fluid within the chamber.
  • In another embodiment, the controller directs separation in the centrifuge either radially or axially due to gravity according to nature of the input fluid such as blood containing the sample.
  • In a further embodiment, the primary carrier fluid velocity is in the range of 1 m/s to 20 m/s.
  • In one embodiment, the thermal cycling stage comprises a microfluidic thermal device comprising a thermal zone comprising a sample inlet for flow of sample through a sample channel while enveloped in the primary carrier fluid, and a thermal carrier inlet for flow of a thermal carrier fluid to heat or cool the sample by heat conduction through the primary carrier fluid.
  • In another embodiment, the microfluidic thermal device thermal zone further comprises separate sample and thermal outlets positioned to allow flow of thermal carrier fluid into and out of contact with the primary carrier fluid.
  • In a further embodiment, there is at least one pair of opposed thermal carrier inlet/outlet pairs on opposed sides of a sample channel.
  • In one embodiment, the thermal cycling stage comprises a plurality of thermal zones.
  • In one embodiment, the microfluidic thermal device comprises a plurality of thermal zones in series.
  • In another embodiment, the thermal cycling stage comprises a plurality of microfluidic thermal devices in series.
  • In a further embodiment, the microfluidic thermal device comprises a closed sample channel for re-circulation of sample with successive heating or cooling in successive thermal zones.
  • In one embodiment, the controller directs flow of the thermal and primary carrier fluids to control flowrate of sample by enveloping within the primary carrier fluid and by viscous drag between the thermal carrier fluid and the primary carrier fluid.
  • In another embodiment, the primary carrier fluid is biologically non-reactive.
  • In a further embodiment, the primary carrier fluid is a silicone oil.
  • In one embodiment, the thermal carrier fluid is biologically non-reactive.
  • In another embodiment, the thermal carrier fluid is a silicone oil.
  • In a further embodiment, the temperatures and flowrates of the carrier fluids are controlled to achieve a temperature ramping gradient of 17° C./sec to 25° C./sec.
  • DETAILED DESCRIPTION OF THE INVENTION Brief Description of the Drawings
  • The invention will be more clearly understood from the following description of some embodiments thereof, given by way of example only with reference to the accompanying drawings in which:
  • FIG. 1 is a diagram of an analysis system of the invention.
  • FIG. 2 is a diagrammatic plan view of a centrifuge of the system, and FIG. 3 is a simulation diagram showing centrifuging;
  • FIG. 4 is a perspective view of the main body of a microfluidic beater of the system;
  • FIG. 5 is a prediction velocity and temperature plot along a thermal stage of the heater;
  • FIG. 6 is a centre line temperature profile in the flow direction showing fast response of same in the heated zone; and
  • FIG. 7 is a plan view of an alternative microfluidic heater.
  • DESCRIPTION OF THE EMBODIMENTS
  • Referring to FIG. 1 an analysis system 1 comprises a controller 2 which interfaces with various stages. A carrier fluid supply 4 delivers carrier fluid to a macro pump 5 which delivers it at a high flowrate to a sample preparation stage 6. The latter also receives a bio-fluid sample, and centrifuges the sample in a vortex created by carrier fluid flow, as described in more detail below. Reactants are supplied by a supply 8 to a flow controller 7 which delivers streams of separated DNA with reactants enveloped in carrier fluid to a thermal cycling stage 9. The DNA is amplified in the stage 9 and optically detected by a detection stage 10. Throughout the process the samples are enveloped in a biologically non-reactive carrier fluid such as silicone oil. This avoids risk of contamination from residual molecules on system channel surfaces.
  • Referring to FIG. 2 a centrifuge device 20 of the sample preparation stage 6 is illustrated diagrammatically. It comprises opposed carrier supply lines 21 and 22 and a central vortex chamber 23 having a sample inlet out of the plane of the page. The centrifuge 20 operates by primary carrier fluid in the channels 21 and 22 driving sample fluid in the chamber 23 into a vortex via viscous forces at the interface between the two fluids. In this embodiment, the carrier fluid is silicone oil mixed to be neutrally buoyant with the sample.
  • The vortex, or centrifuge, is thus established without any mechanical moving parts. The carrier fluid drives a vortex of the sample to be centrifuged thereby avoiding the very many difficulties of designing and operating moving parts at the micro scale, particularly at high rotational speeds. FIG. 3 illustrates the centrifuging activity, the greater density of dots indicating higher flow velocities. The left-hand scale shows the velocity range of 1 m/s to 20 m/s. The sample is wrapped in an initial volume of carrier fluid within the chamber 23 to prevent surface contamination.
  • This achieves a continuous throughput micro-centrifuging to suitably extract DNA and RNA from cellular material. The bio-fluid is centrifuged resulting in DNA and other bio-molecules of interest accumulating at the bottom of the chamber, thereby providing an efficient and simple method of manipulating micron and sub-micron quantities of bio-fluid. The DNA and RNA are separated due to the greater weight and viscous resistance of the DNA. Numerical simulations (FIG. 3) of the flow show that tangential velocities of up to 10 ms−1 are generated towards the edge of the vortex core. Calculations reveal this to be equivalent to a rotational speed of almost 20,000 rpm or 2,000 g in terms of a centrifugal force. In order to achieve these levels of centrifugal force, the carrier fluid is pumped at speeds of 5 ms−1 through the system. In general, the desired carrier fluid speed is 1 m/s to 20 m/s. The device has further potential to be miniaturized to centrifuge at up to 200,000 g, as these levels of force are necessary for efficient separation of RNA and other smaller cellular constituents and bio-molecules.
  • Overall, the continuous throughput centrifuge offers many benefits over conventional technology. The device may also function as a fluid mixing device by reversing the flow path of one of the carrier fluid, if such is desired for an application. It is modular in nature, meaning two or more systems can be placed together in any configuration and run by the same control and power source system. The centrifuge 20 has no moving parts thereby allowing excellent reliability compared with a system having moving pans. An important consequence of this feature is that manufacturing this device at the micro-scale using current silicon processing or micro-machining is readily achievable.
  • Referring to FIG. 4 a microfluidic thermal device 51 of the stage 9 is shown. It comprises three successive thermal zones 52, 53, and 54. Each zone comprises a sample inlet 60 and an outlet 61 for flow of the bio sample in the primary carrier fluid. There are also a pair of thermal carrier inlets 65 and 66, and a pair of thermal carrier outlets 67 and 68 for each of the three zones. This drawing shows only the main body, there also being top and bottom sealing transparent plates.
  • The bio sample which enters the sample inlet 60 of each stage is enveloped and conveyed by the carrier fluid henceforth called the “primary carrier fluid”. Thermal carrier fluid is delivered at the inlets 65 and 66 to heat or cool the bio sample via the primary carrier fluid.
  • As the sample remains in a low shear rate region of the flow, mass transport by diffusion of sample species is kept to a minimum. The low shear region reduces damage by shear to macro molecules that may be carried by the bio sample. The arrangement of a number (in this case three) of thermal zones in series offers advantages to applications such as the polymerase chain reaction (PCR) where rapid and numerous thermal cycles lead to dramatic amplification of a DNA template strand.
  • The device 51 also acts as an ejector pump, in which the velocity and hence the residency time of the sample is controlled by controlling velocity of one or both of the carriers fluids. The carrier flow parameters determine how long the sample remains at the set temperature in each zone. This is often important, as chemical reactions require particular times for completion. The device 51 can therefore be tuned to the required residency times and ramp rates by controlling the carrier velocity.
  • Referring to FIG. 5 a predicted velocity contour map at the mid-height plane of a zone channel is shown. Carrier fluid enters through the channels at the top and bottom left of the image and exits through the channels at the top and bottom right of the image. The sample fluid enters and exits through the central channel. The different shadings of this map indicate the velocities, the range being 0.01 m/s to 0.1 m/s.
  • In one example, sample fluid enters through the central channel at the left of the image at a temperature of 50° C. and is heated to 70° C. by the thermal carrier fluid.
  • FIG. 6 shows a temperature profile along a longitudinal centerline of a thermal zone. A target temperature of 342 K is achieved within an extremely short distance from entrance, achieving an excellent temperature ramp rate of 20° C./sec over a distance of 0.05 m. In general, a ramping of 17° C./sec to 25° C./sec is desirable for many applications.
  • The following table sets out parameters for one example. A silicone oil, density matched to the density of the bio sample, is used for both of the carrier fluids.
  • TABLE 1
    Boundary Conditions and Fluid Properties
    Overall Channel Dimensions 5 mm × 5 mm × 200 mm
    Wall Boundary Condition outside of carrier Adiabatic
    flow interaction zones
    Heat Transfer Carrier Fluid Inlet temperature 70° C., 90° C., 110° C.
    for each zone
    Sample/Transport Carrier Inlet Pressure   0 Pa
    Heat Transfer Carrier Fluid Inlet Pressure 0.2 Pa
    Sample/Transport Carrier Outlet Pressure 1.9 Pa
    Heat Transfer Carrier Fluid Outlet Pressure 1.7 Pa
    Mass Diffusivity 1.3E−12 m2/s
    Approximate Temperature Gradient in Zones 20° C./sec
  • Referring to FIG. 7, another microfluidic thermal device, 70, is shown. There are again three thermal zones, however in this case on a generally rectangular closed circuit, with zones 71, 72, and 73. The zones 71 and 73 are on one side and there is only a single zone, 72, on the other side. The thermal carrier fluid is silicone oil, as is the primary carrier fluid. The thermal carrier fluid for the zone 71 is at 68° C., to ramp up the bio sample to this temperature during residency in this zone. The zones 72 and 73 provide outlet temperatures of 95° C. and 72° C. respectively.
  • The optical detection stage 10 is positioned over the microfluidic device 70 to analyse the sample. The silicone oil is sufficiently transparent to detect the fluorescently tagged molecules.
  • It will be appreciated that the invention achieves comprehensive control over bio sample flowrate and temperature, with no risk of contamination from device surfaces. The invention also achieves integrated pumping and thermal cycling of the sample without moving parts at the microscale. There are very high throughputs as measured by processing time for one sample.
  • The system is expected to have a low cost and high reliability due to the absence of micro scale moving parts. The system also allows independent control and variation of all PCR parameters for process optimisation.
  • The invention is not limited to the embodiments described but may be varied in construction and detail.

Claims (10)

1.-20. (canceled)
21. A method for analyzing rare mutated cells from a sample of bodily fluid or tissue using polymerase chain reaction (PCR), the method comprising:
forming droplets enveloped in an immiscible carrier fluid, wherein the droplets are configured to capture nucleic acid molecules from at least some rare mutated cells;
extracting the nucleic acid molecules from the at least some rare mutated cells;
amplifying the nucleic acid molecules from the at least some rare mutated cells with PCR;
analyzing the nucleic acid molecules from the at least some rare mutated cells, wherein the analysis is configured to target cells that occur about one part in 106.
22. The method of claim 21, wherein analyzing the nucleic acid molecules further includes hybridizing labeled probes to the nucleic acid molecules for optical detection.
23. The method of claim 21, wherein amplifying the nucleic acid molecules further includes continuously flowing the droplets enveloped in the immiscible carrier fluid through a plurality of thermal zones.
24. The method of claim 21, wherein amplifying the nucleic acid molecules is performed by PCR in the droplets.
25. The method of claim 21, wherein amplifying the nucleic acid molecules is performed in a microfluidic device.
26. The method of claim 25, wherein analyzing the nucleic acid molecules is performed in the microfluidic device.
27. The method of claim 21, wherein a fluid stream delivers one or more reactants for amplifying the nucleic acid molecules.
28. The method of claim 21, wherein the nucleic acid molecules are RNA.
29. The method of claim 21, wherein the nucleic acid molecules are DNA.
US15/278,894 2003-09-05 2016-09-28 Microfluidic analysis system Active 2025-09-21 US10676786B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US15/278,894 US10676786B2 (en) 2003-09-05 2016-09-28 Microfluidic analysis system
US16/892,488 US11807902B2 (en) 2003-09-05 2020-06-04 Microfluidic analysis system

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US50034403P 2003-09-05 2003-09-05
US50034503P 2003-09-05 2003-09-05
PCT/IE2004/000115 WO2005023427A1 (en) 2003-09-05 2004-09-06 A microfluidic analysis system
US11/366,524 US7622076B2 (en) 2003-09-05 2006-03-03 Microfluidic analysis system
US12/617,286 US20100092987A1 (en) 2003-09-05 2009-11-12 Microfluidic analysis system
US15/278,894 US10676786B2 (en) 2003-09-05 2016-09-28 Microfluidic analysis system

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/617,286 Division US20100092987A1 (en) 2003-09-05 2009-11-12 Microfluidic analysis system

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/892,488 Continuation US11807902B2 (en) 2003-09-05 2020-06-04 Microfluidic analysis system

Publications (2)

Publication Number Publication Date
US20170081705A1 true US20170081705A1 (en) 2017-03-23
US10676786B2 US10676786B2 (en) 2020-06-09

Family

ID=34278702

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/366,524 Active 2026-06-01 US7622076B2 (en) 2003-09-05 2006-03-03 Microfluidic analysis system
US12/617,286 Abandoned US20100092987A1 (en) 2003-09-05 2009-11-12 Microfluidic analysis system
US15/278,894 Active 2025-09-21 US10676786B2 (en) 2003-09-05 2016-09-28 Microfluidic analysis system
US16/892,488 Active 2025-04-19 US11807902B2 (en) 2003-09-05 2020-06-04 Microfluidic analysis system

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US11/366,524 Active 2026-06-01 US7622076B2 (en) 2003-09-05 2006-03-03 Microfluidic analysis system
US12/617,286 Abandoned US20100092987A1 (en) 2003-09-05 2009-11-12 Microfluidic analysis system

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/892,488 Active 2025-04-19 US11807902B2 (en) 2003-09-05 2020-06-04 Microfluidic analysis system

Country Status (3)

Country Link
US (4) US7622076B2 (en)
EP (1) EP1663497B2 (en)
WO (1) WO2005023427A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10967338B2 (en) 2003-09-05 2021-04-06 Stokes Bio Ltd. Methods of releasing and analyzing cellular components
WO2021201819A1 (en) * 2020-03-30 2021-10-07 Hewlett-Packard Development Company, L.P. Intermittent warming of a biologic sample including a nucleic acid
US11772096B2 (en) 2006-02-07 2023-10-03 Stokes Bio Ltd. System for processing biological sample
US11788120B2 (en) 2017-11-27 2023-10-17 The Trustees Of Columbia University In The City Of New York RNA printing and sequencing devices, methods, and systems

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663497B2 (en) 2003-09-05 2020-03-25 Stokes Bio Limited A microfluidic analysis system
US8968659B2 (en) 2003-09-05 2015-03-03 Stokes Bio Limited Sample dispensing
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
EP3913375A1 (en) 2006-01-11 2021-11-24 Bio-Rad Laboratories, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US8735169B2 (en) 2006-02-07 2014-05-27 Stokes Bio Limited Methods for analyzing agricultural and environmental samples
US8501497B2 (en) 2006-02-07 2013-08-06 Stokes Bio Limited Forming sample combinations using liquid bridge systems
US20080280331A1 (en) * 2006-02-07 2008-11-13 Stokes Bio Limited Microfluidic Analysis System
US20100304446A1 (en) * 2006-02-07 2010-12-02 Stokes Bio Limited Devices, systems, and methods for amplifying nucleic acids
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
US20080014589A1 (en) 2006-05-11 2008-01-17 Link Darren R Microfluidic devices and methods of use thereof
EP2069070B1 (en) * 2006-09-28 2013-11-27 Stokes Bio Limited A qpcr analysis apparatus
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008116941A1 (en) 2007-03-26 2008-10-02 Fundación Gaiker Method and device for detecting genetic material by means of polymerase chain reaction
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
WO2010133965A2 (en) 2009-05-19 2010-11-25 Life Technologies Corporation Sampling device
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP3392349A1 (en) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
EP3447155A1 (en) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwich assays in droplets
EP2673382B1 (en) * 2011-02-11 2020-05-06 Bio-Rad Laboratories, Inc. Thermocycling device for nucleic acid amplification and methods of use
WO2012109600A2 (en) 2011-02-11 2012-08-16 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
CN103917293B (en) 2011-04-08 2016-01-20 斯多克斯生物有限公司 Biological detection system and using method
WO2012139041A1 (en) 2011-04-08 2012-10-11 Stokes Bio Limited System and method for charging fluids
EP3709018A1 (en) 2011-06-02 2020-09-16 Bio-Rad Laboratories, Inc. Microfluidic apparatus for identifying components of a chemical reaction
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US9855559B2 (en) 2011-12-30 2018-01-02 Abbott Molecular Inc. Microorganism nucleic acid purification from host samples
US10323279B2 (en) 2012-08-14 2019-06-18 10X Genomics, Inc. Methods and systems for processing polynucleotides
US11591637B2 (en) 2012-08-14 2023-02-28 10X Genomics, Inc. Compositions and methods for sample processing
MX364957B (en) 2012-08-14 2019-05-15 10X Genomics Inc Microcapsule compositions and methods.
US10400280B2 (en) 2012-08-14 2019-09-03 10X Genomics, Inc. Methods and systems for processing polynucleotides
US9701998B2 (en) 2012-12-14 2017-07-11 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10533221B2 (en) 2012-12-14 2020-01-14 10X Genomics, Inc. Methods and systems for processing polynucleotides
WO2014124338A1 (en) 2013-02-08 2014-08-14 10X Technologies, Inc. Polynucleotide barcode generation
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
US9824068B2 (en) 2013-12-16 2017-11-21 10X Genomics, Inc. Methods and apparatus for sorting data
CN106795553B (en) 2014-06-26 2021-06-04 10X基因组学有限公司 Methods of analyzing nucleic acids from individual cells or cell populations
US10221436B2 (en) 2015-01-12 2019-03-05 10X Genomics, Inc. Processes and systems for preparation of nucleic acid sequencing libraries and libraries prepared using same
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
US11371094B2 (en) 2015-11-19 2022-06-28 10X Genomics, Inc. Systems and methods for nucleic acid processing using degenerate nucleotides
US11081208B2 (en) 2016-02-11 2021-08-03 10X Genomics, Inc. Systems, methods, and media for de novo assembly of whole genome sequence data
US10815525B2 (en) 2016-12-22 2020-10-27 10X Genomics, Inc. Methods and systems for processing polynucleotides
US10550429B2 (en) 2016-12-22 2020-02-04 10X Genomics, Inc. Methods and systems for processing polynucleotides
EP4029939B1 (en) 2017-01-30 2023-06-28 10X Genomics, Inc. Methods and systems for droplet-based single cell barcoding
US10995333B2 (en) 2017-02-06 2021-05-04 10X Genomics, Inc. Systems and methods for nucleic acid preparation
US10544413B2 (en) 2017-05-18 2020-01-28 10X Genomics, Inc. Methods and systems for sorting droplets and beads
EP3625353B1 (en) 2017-05-18 2022-11-30 10X Genomics, Inc. Methods and systems for sorting droplets and beads
US20190064173A1 (en) 2017-08-22 2019-02-28 10X Genomics, Inc. Methods of producing droplets including a particle and an analyte
US10837047B2 (en) 2017-10-04 2020-11-17 10X Genomics, Inc. Compositions, methods, and systems for bead formation using improved polymers
WO2019083852A1 (en) 2017-10-26 2019-05-02 10X Genomics, Inc. Microfluidic channel networks for partitioning
WO2019084043A1 (en) 2017-10-26 2019-05-02 10X Genomics, Inc. Methods and systems for nuclecic acid preparation and chromatin analysis
CN111479631B (en) 2017-10-27 2022-02-22 10X基因组学有限公司 Methods and systems for sample preparation and analysis
EP3954782A1 (en) 2017-11-15 2022-02-16 10X Genomics, Inc. Functionalized gel beads
WO2019108851A1 (en) 2017-11-30 2019-06-06 10X Genomics, Inc. Systems and methods for nucleic acid preparation and analysis
WO2019157529A1 (en) 2018-02-12 2019-08-15 10X Genomics, Inc. Methods characterizing multiple analytes from individual cells or cell populations
US11639928B2 (en) 2018-02-22 2023-05-02 10X Genomics, Inc. Methods and systems for characterizing analytes from individual cells or cell populations
US11471884B2 (en) 2018-04-02 2022-10-18 Dropworks, Inc. Systems and methods for serial flow emulsion processes
WO2019195166A1 (en) 2018-04-06 2019-10-10 10X Genomics, Inc. Systems and methods for quality control in single cell processing
US11703427B2 (en) 2018-06-25 2023-07-18 10X Genomics, Inc. Methods and systems for cell and bead processing
US20200032335A1 (en) 2018-07-27 2020-01-30 10X Genomics, Inc. Systems and methods for metabolome analysis
US11459607B1 (en) 2018-12-10 2022-10-04 10X Genomics, Inc. Systems and methods for processing-nucleic acid molecules from a single cell using sequential co-partitioning and composite barcodes
US11845983B1 (en) 2019-01-09 2023-12-19 10X Genomics, Inc. Methods and systems for multiplexing of droplet based assays
US11851683B1 (en) 2019-02-12 2023-12-26 10X Genomics, Inc. Methods and systems for selective analysis of cellular samples
WO2020168013A1 (en) 2019-02-12 2020-08-20 10X Genomics, Inc. Methods for processing nucleic acid molecules
US11467153B2 (en) 2019-02-12 2022-10-11 10X Genomics, Inc. Methods for processing nucleic acid molecules
US11655499B1 (en) 2019-02-25 2023-05-23 10X Genomics, Inc. Detection of sequence elements in nucleic acid molecules
US11920183B2 (en) 2019-03-11 2024-03-05 10X Genomics, Inc. Systems and methods for processing optically tagged beads
US11851700B1 (en) 2020-05-13 2023-12-26 10X Genomics, Inc. Methods, kits, and compositions for processing extracellular molecules
CN113607586A (en) * 2021-07-19 2021-11-05 国网浙江省电力有限公司经济技术研究院 Drop-wall flow separation test device

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180346A1 (en) * 2003-03-14 2004-09-16 The Regents Of The University Of California. Chemical amplification based on fluid partitioning

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2572180B1 (en) 1984-10-24 1987-03-20 Eric Marteau D Autry METHOD AND APPARATUS FOR REPAIRING SAMPLES FOR ANALYSIS
US5102517A (en) 1990-05-23 1992-04-07 Millipore Corporation Capillary wash system
US5641622A (en) 1990-09-13 1997-06-24 Baxter International Inc. Continuous centrifugation process for the separation of biological components from heterogeneous cell populations
US5270183A (en) 1991-02-08 1993-12-14 Beckman Research Institute Of The City Of Hope Device and method for the automated cycling of solutions between two or more temperatures
ATE208658T1 (en) 1993-07-28 2001-11-15 Pe Corp Ny APPARATUS AND METHOD FOR NUCLEIC ACID DUPLICATION
US6143496A (en) 1997-04-17 2000-11-07 Cytonix Corporation Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
DE19736691A1 (en) * 1997-08-22 1999-02-25 Michael Prof Dr Med Giesing Characterising and identifying disseminated metastatic cancer cells
WO1999041015A1 (en) * 1998-02-11 1999-08-19 Institut für Physikalische Hochtechnologie e.V. Miniaturized temperature-zone flow reactor
US6306590B1 (en) 1998-06-08 2001-10-23 Caliper Technologies Corp. Microfluidic matrix localization apparatus and methods
US6261431B1 (en) * 1998-12-28 2001-07-17 Affymetrix, Inc. Process for microfabrication of an integrated PCR-CE device and products produced by the same
US6294063B1 (en) * 1999-02-12 2001-09-25 Board Of Regents, The University Of Texas System Method and apparatus for programmable fluidic processing
US20020182749A1 (en) 1999-05-11 2002-12-05 Aclara Biosciences, Inc. Sample evaporative control
US6193471B1 (en) 1999-06-30 2001-02-27 Perseptive Biosystems, Inc. Pneumatic control of formation and transport of small volume liquid samples
US6524456B1 (en) 1999-08-12 2003-02-25 Ut-Battelle, Llc Microfluidic devices for the controlled manipulation of small volumes
US6355164B1 (en) * 1999-10-29 2002-03-12 Ontogen Corporation Sample collection apparatus and method for multiple channel high throughput purification
US6481453B1 (en) 2000-04-14 2002-11-19 Nanostream, Inc. Microfluidic branch metering systems and methods
WO2001089691A2 (en) 2000-05-24 2001-11-29 Micronics, Inc. Capillaries for fluid movement within microfluidic channels
WO2001089696A2 (en) 2000-05-24 2001-11-29 Micronics, Inc. Microfluidic concentration gradient loop
US20010048637A1 (en) 2000-05-24 2001-12-06 Weigl Bernhard H. Microfluidic system and method
DE10055318A1 (en) 2000-06-09 2001-12-20 Advalytix Ag Process for specific directed manipulation of small amounts of materials on solid body surfaces comprises producing an impulse along the solid body surface, and causing the impulse
ATE448875T1 (en) 2000-09-14 2009-12-15 Caliper Life Sciences Inc MICROFLUIDIC DEVICES AND METHODS FOR CARRYING OUT TEMPERATURE-MEDIATED REACTIONS
EP1334347A1 (en) 2000-09-15 2003-08-13 California Institute Of Technology Microfabricated crossflow devices and methods
GB0026404D0 (en) 2000-10-28 2000-12-13 Siddall & Hilton Ltd Body support arrangements
EP1343973B2 (en) 2000-11-16 2020-09-16 California Institute Of Technology Apparatus and methods for conducting assays and high throughput screening
WO2002072264A1 (en) 2001-03-09 2002-09-19 Biomicro Systems, Inc. Method and system for microfluidic interfacing to arrays
CA2442978A1 (en) 2001-04-04 2002-10-17 Bioprocessors Corp. System and method for dispensing liquids
US7077152B2 (en) 2001-07-07 2006-07-18 Nanostream, Inc. Microfluidic metering systems and methods
AUPR707101A0 (en) * 2001-08-16 2001-09-06 Corbett Research Pty Ltd Continuous flow thermal device
US6907895B2 (en) 2001-09-19 2005-06-21 The United States Of America As Represented By The Secretary Of Commerce Method for microfluidic flow manipulation
US20030073089A1 (en) 2001-10-16 2003-04-17 Mauze Ganapati R. Companion cartridge for disposable diagnostic sensing platforms
US7189580B2 (en) 2001-10-19 2007-03-13 Wisconsin Alumni Research Foundation Method of pumping fluid through a microfluidic device
US20030138819A1 (en) 2001-10-26 2003-07-24 Haiqing Gong Method for detecting disease
WO2003057010A2 (en) 2002-01-04 2003-07-17 Board Of Regents, The University Of Texas System Droplet-based microfluidic oligonucleotide synthesis engine
US7718099B2 (en) 2002-04-25 2010-05-18 Tosoh Corporation Fine channel device, fine particle producing method and solvent extraction method
FR2839504B1 (en) * 2002-05-07 2004-06-18 Commissariat Energie Atomique DEVICE AND METHOD FOR DISPENSING LIQUID PRODUCTS
EP2282214B1 (en) 2002-05-09 2022-10-05 The University of Chicago Device and method for pressure-driven plug transport and reaction
US7901939B2 (en) 2002-05-09 2011-03-08 University Of Chicago Method for performing crystallization and reactions in pressure-driven fluid plugs
GB2395196B (en) 2002-11-14 2006-12-27 Univ Cardiff Microfluidic device and methods for construction and application
US7547380B2 (en) * 2003-01-13 2009-06-16 North Carolina State University Droplet transportation devices and methods having a fluid surface
GB0315438D0 (en) 2003-07-02 2003-08-06 Univ Manchester Analysis of mixed cell populations
US7767435B2 (en) * 2003-08-25 2010-08-03 University Of Washington Method and device for biochemical detection and analysis of subcellular compartments from a single cell
EP1663497B2 (en) 2003-09-05 2020-03-25 Stokes Bio Limited A microfluidic analysis system
US9597644B2 (en) 2003-09-05 2017-03-21 Stokes Bio Limited Methods for culturing and analyzing cells
US8968659B2 (en) 2003-09-05 2015-03-03 Stokes Bio Limited Sample dispensing
JP4341372B2 (en) 2003-10-30 2009-10-07 コニカミノルタホールディングス株式会社 Liquid mixing method, mixing apparatus and mixing system
US7687269B2 (en) * 2003-12-10 2010-03-30 Northeastern University Method for efficient transport of small liquid volumes to, from or within microfluidic devices
WO2005080606A1 (en) 2004-02-18 2005-09-01 Xiaochuan Zhou Fluidic devices and methods for multiplex chemical and biochemical reactions
KR100552706B1 (en) 2004-03-12 2006-02-20 삼성전자주식회사 Method and apparatus for nucleic acid amplification
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US20050272144A1 (en) 2004-06-08 2005-12-08 Konica Minolta Medical & Graphic, Inc. Micro-reactor for improving efficiency of liquid mixing and reaction
US7655470B2 (en) 2004-10-29 2010-02-02 University Of Chicago Method for manipulating a plurality of plugs and performing reactions therein in microfluidic systems
WO2006089192A2 (en) 2005-02-18 2006-08-24 Canon U.S. Life Sciences, Inc. Devices and methods for identifying genomic dna of organisms
US20070014695A1 (en) 2005-04-26 2007-01-18 Applera Corporation Systems and Methods for Multiple Analyte Detection
EP2660482B1 (en) 2005-08-22 2019-08-07 Life Technologies Corporation Vorrichtung, System und Verfahren unter Verwendung von nichtmischbaren Flüssigkeiten mit unterschiedlichen Volumen
US20070134209A1 (en) * 2005-12-12 2007-06-14 Metafluidics, Inc. Cellular encapsulation for self-assembly of engineered tissue
US20080280331A1 (en) 2006-02-07 2008-11-13 Stokes Bio Limited Microfluidic Analysis System
US8735169B2 (en) 2006-02-07 2014-05-27 Stokes Bio Limited Methods for analyzing agricultural and environmental samples
US8501497B2 (en) 2006-02-07 2013-08-06 Stokes Bio Limited Forming sample combinations using liquid bridge systems
EP1981625B1 (en) 2006-02-07 2010-08-18 Stokes Bio Limited A microfluidic droplet queuing network and method
ATE523244T1 (en) 2006-02-07 2011-09-15 Stokes Bio Ltd LIQUID BRIDGE SYSTEM AND METHOD
US8492168B2 (en) 2006-04-18 2013-07-23 Advanced Liquid Logic Inc. Droplet-based affinity assays
US20080014589A1 (en) 2006-05-11 2008-01-17 Link Darren R Microfluidic devices and methods of use thereof
EP2069070B1 (en) 2006-09-28 2013-11-27 Stokes Bio Limited A qpcr analysis apparatus
US8202686B2 (en) 2007-03-22 2012-06-19 Advanced Liquid Logic, Inc. Enzyme assays for a droplet actuator
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP4047367A1 (en) * 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
US20100059120A1 (en) 2008-09-11 2010-03-11 General Electric Company Microfluidic device and methods for droplet generation and manipulation
US8697011B2 (en) 2009-05-19 2014-04-15 Stokes Bio Limited Sampling device with immiscible fluid supply tube in counter-flow arrangement
US9625454B2 (en) 2009-09-04 2017-04-18 The Research Foundation For The State University Of New York Rapid and continuous analyte processing in droplet microfluidic devices
EP3392349A1 (en) 2010-02-12 2018-10-24 Raindance Technologies, Inc. Digital analyte analysis
CA2946144A1 (en) 2014-04-21 2015-10-29 President And Fellows Of Harvard College Systems and methods for barcoding nucleic acids

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180346A1 (en) * 2003-03-14 2004-09-16 The Regents Of The University Of California. Chemical amplification based on fluid partitioning

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10967338B2 (en) 2003-09-05 2021-04-06 Stokes Bio Ltd. Methods of releasing and analyzing cellular components
US11772096B2 (en) 2006-02-07 2023-10-03 Stokes Bio Ltd. System for processing biological sample
US11788120B2 (en) 2017-11-27 2023-10-17 The Trustees Of Columbia University In The City Of New York RNA printing and sequencing devices, methods, and systems
WO2021201819A1 (en) * 2020-03-30 2021-10-07 Hewlett-Packard Development Company, L.P. Intermittent warming of a biologic sample including a nucleic acid

Also Published As

Publication number Publication date
EP1663497B1 (en) 2014-08-27
US20200354772A1 (en) 2020-11-12
US20100092987A1 (en) 2010-04-15
US20060205062A1 (en) 2006-09-14
WO2005023427A1 (en) 2005-03-17
US7622076B2 (en) 2009-11-24
EP1663497B2 (en) 2020-03-25
EP1663497A1 (en) 2006-06-07
US11807902B2 (en) 2023-11-07
US10676786B2 (en) 2020-06-09

Similar Documents

Publication Publication Date Title
US11807902B2 (en) Microfluidic analysis system
US10543466B2 (en) High resolution temperature profile creation in a digital microfluidic device
Yuen et al. Microchip module for blood sample preparation and nucleic acid amplification reactions
US10239057B2 (en) Microfluidic devices and methods for cell analysis and molecular diagnostics
AU2008222590B2 (en) Apparatus and method for nucleic acid amplification
EP0637999B1 (en) Polynucleotide amplification analysis using a microfabricated device
KR102127231B1 (en) Plurality Of Reaction Chambers In A Test Cartridge
WO2004073863A2 (en) Chemical reactions apparatus
US20120045765A1 (en) Composite liquid cells
US20070190641A1 (en) Mesoscale polynucleotide amplification device and method
Lien et al. Miniaturization of molecular biological techniques for gene assay
WO2005082535A1 (en) Buoyancy-driven microfluidics
KR100579831B1 (en) Microfluidic sample processing apparatus capable of assembling
Kye et al. Separation, purification, and detection of cfDNA in a microfluidic device
KR102043103B1 (en) Automatic genetic detector
IE20040589A1 (en) A microfluidic analysis system
IE84099B1 (en) A microfluidic analysis system
US20230008992A1 (en) Devices for generating pre-templated instant partitions
Brahmasandra et al. A microfabricated fluidic reaction and separation system for integrated DNA analysis
US20160375441A1 (en) Apparatus and method for nucleic acid amplification
CN116083223A (en) Nucleic acid detection equipment and system
IE20050100A1 (en) Microfluidics
IE84261B1 (en) Microfluidics
WO2014113663A1 (en) In-line polymerase chain reaction

Legal Events

Date Code Title Description
AS Assignment

Owner name: STOKES BIO LTD., IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:DAVIES, MARK;DALTON, TARA;REEL/FRAME:046583/0095

Effective date: 20091208

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4